BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32210430)

  • 1. Molecular subtypes in canine hemangiosarcoma reveal similarities with human angiosarcoma.
    Wang G; Wu M; Durham AC; Radaelli E; Mason NJ; Xu X; Roth DB
    PLoS One; 2020; 15(3):e0229728. PubMed ID: 32210430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actionable mutations in canine hemangiosarcoma.
    Wang G; Wu M; Maloneyhuss MA; Wojcik J; Durham AC; Mason NJ; Roth DB
    PLoS One; 2017; 12(11):e0188667. PubMed ID: 29190660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic landscapes of canine splenic angiosarcoma (hemangiosarcoma) contain extensive heterogeneity within and between patients.
    Wong S; Ehrhart EJ; Stewart S; Zismann V; Cawley J; Halperin R; Briones N; Richter K; Sivaprakasam K; Perdigones N; Contente-Cuomo T; Facista S; Trent JM; Murtaza M; Khanna C; Hendricks WPD
    PLoS One; 2022; 17(7):e0264986. PubMed ID: 35867969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the oncogenomic landscape of canine and feline hemangiosarcoma shows novel parallels with human angiosarcoma.
    Wong K; Ludwig L; Krijgsman O; Adams DJ; Wood GA; van der Weyden L
    Dis Model Mech; 2021 Jul; 14(7):. PubMed ID: 34296746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of genomic alterations with clinical impact in canine splenic hemangiosarcoma.
    Estabrooks T; Gurinovich A; Pietruska J; Lewis B; Harvey G; Post G; Lambert L; Miller A; Rodrigues L; White ME; Lopes C; London CA; Megquier K
    Vet Comp Oncol; 2023 Dec; 21(4):623-633. PubMed ID: 37734854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Genomics Reveals Shared Mutational Landscape in Canine Hemangiosarcoma and Human Angiosarcoma.
    Megquier K; Turner-Maier J; Swofford R; Kim JH; Sarver AL; Wang C; Sakthikumar S; Johnson J; Koltookian M; Lewellen M; Scott MC; Schulte AJ; Borst L; Tonomura N; Alfoldi J; Painter C; Thomas R; Karlsson EK; Breen M; Modiano JF; Elvers I; Lindblad-Toh K
    Mol Cancer Res; 2019 Dec; 17(12):2410-2421. PubMed ID: 31570656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomically Complex Human Angiosarcoma and Canine Hemangiosarcoma Establish Convergent Angiogenic Transcriptional Programs Driven by Novel Gene Fusions.
    Kim JH; Megquier K; Thomas R; Sarver AL; Song JM; Kim YT; Cheng N; Schulte AJ; Linden MA; Murugan P; Oseth L; Forster CL; Elvers I; Swofford R; Turner-Maier J; Karlsson EK; Breen M; Lindblad-Toh K; Modiano JF
    Mol Cancer Res; 2021 May; 19(5):847-861. PubMed ID: 33649193
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Maeda M; Ochiai K; Michishita M; Morimatsu M; Sakai H; Kinoshita N; Sakaue M; Onozawa E; Azakami D; Yamamoto M; Ishioka K; Sadahira T; Watanabe M; Tanaka Y
    Oncol Rep; 2022 Apr; 47(4):. PubMed ID: 35234262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-214 Promotes Apoptosis in Canine Hemangiosarcoma by Targeting the COP1-p53 Axis.
    Heishima K; Mori T; Sakai H; Sugito N; Murakami M; Yamada N; Akao Y; Maruo K
    PLoS One; 2015; 10(9):e0137361. PubMed ID: 26335793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Profile of Canine Hemangiosarcoma and Potential Novel Therapeutic Targets.
    Pimentel PAB; Giuliano A; Bęczkowski PM; Horta RDS
    Vet Sci; 2023 Jun; 10(6):. PubMed ID: 37368773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New molecular targets in canine hemangiosarcoma-Comparative review and future of the precision medicine.
    Kapturska KM; Pawlak A
    Vet Comp Oncol; 2023 Sep; 21(3):357-377. PubMed ID: 37308243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PIK3CA mutations matter for cancer in dogs.
    Kim JH
    Res Vet Sci; 2020 Dec; 133():39-41. PubMed ID: 32932196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent PTPRB and PLCG1 mutations in angiosarcoma.
    Behjati S; Tarpey PS; Sheldon H; Martincorena I; Van Loo P; Gundem G; Wedge DC; Ramakrishna M; Cooke SL; Pillay N; Vollan HKM; Papaemmanuil E; Koss H; Bunney TD; Hardy C; Joseph OR; Martin S; Mudie L; Butler A; Teague JW; Patil M; Steers G; Cao Y; Gumbs C; Ingram D; Lazar AJ; Little L; Mahadeshwar H; Protopopov A; Al Sannaa GA; Seth S; Song X; Tang J; Zhang J; Ravi V; Torres KE; Khatri B; Halai D; Roxanis I; Baumhoer D; Tirabosco R; Amary MF; Boshoff C; McDermott U; Katan M; Stratton MR; Futreal PA; Flanagan AM; Harris A; Campbell PJ
    Nat Genet; 2014 Apr; 46(4):376-379. PubMed ID: 24633157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromatin run-on sequencing analysis finds that ECM remodeling plays an important role in canine hemangiosarcoma pathogenesis.
    Mukai C; Choi E; Sams KL; Klampen EZ; Anguish L; Marks BA; Rice EJ; Wang Z; Choate LA; Chou SP; Kato Y; Miller AD; Danko CG; Coonrod SA
    BMC Vet Res; 2020 Jun; 16(1):206. PubMed ID: 32571313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of phosphatase and tensin homolog deleted from chromosome 10 in canine hemangiosarcoma.
    Dickerson EB; Thomas R; Fosmire SP; Lamerato-Kozicki AR; Bianco SR; Wojcieszyn JW; Breen M; Helfand SC; Modiano JF
    Vet Pathol; 2005 Sep; 42(5):618-32. PubMed ID: 16145208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic inhibition of MEK signaling prevents growth of canine hemangiosarcoma.
    Andersen NJ; Nickoloff BJ; Dykema KJ; Boguslawski EA; Krivochenitser RI; Froman RE; Dawes MJ; Baker LH; Thomas DG; Kamstock DA; Kitchell BE; Furge KA; Duesbery NS
    Mol Cancer Ther; 2013 Sep; 12(9):1701-14. PubMed ID: 23804705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro effects of PI3K/mTOR inhibition in canine hemangiosarcoma.
    Pyuen AA; Meuten T; Rose BJ; Thamm DH
    PLoS One; 2018; 13(7):e0200634. PubMed ID: 30011343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer effects of resveratrol in canine hemangiosarcoma cell lines.
    Carlson A; Alderete KS; Grant MKO; Seelig DM; Sharkey LC; Zordoky BNM
    Vet Comp Oncol; 2018 Jun; 16(2):253-261. PubMed ID: 29235249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of prostate specific membrane antigen by canine hemangiosarcoma cells provides opportunity for the molecular detection of disease burdens within hemorrhagic body cavity effusions.
    Dowling M; Samuelson J; Fadl-Alla B; Pondenis HC; Byrum M; Barger AM; Fan TM
    PLoS One; 2019; 14(1):e0210297. PubMed ID: 30601866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcome in 20 cases of lingual hemangiosarcoma in dogs: 1996-2011.
    Burton JH; Powers BE; Biller BJ
    Vet Comp Oncol; 2014 Sep; 12(3):198-204. PubMed ID: 22905712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.